ask="45.50"
ask_size="700"
average_daily_volume="1579740"
bid="40.80"
bid_size="100"
book_value="11.83"
change="+1.21"
change_from_200_day_moving_average="-11.11"
change_from_50_day_moving_average="2.19"
change_from_52_week_high="-43.40"
change_From_52_week_low="13.33"
change_in_percent="+2.78%"
close="44.71"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.80"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="44.95"
high_52_weeks="88.11"
last_trade_date="1/10/2017"
last_trade_price="44.71"
last_trade_size="64682"
last_trade_time="4:00pm"
low="42.56"
low_52_weeks="31.38"
market_capitalization="3.84B"
moving_average_200_day="55.82"
moving_average_50_day="42.52"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="61.36"
open="43.23"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="-19.90%"
percent_change_from_50_day_moving_average="+5.15%"
percent_change_from_52_week_high="-49.26%"
percent_change_from_52_week_low="+42.48%"
previous_close="43.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.68"
price_per_sales="100.20"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.52"
stock_exchange="NMS"
symbol="ALNY"
volume="775546"
weeks_range_52="31.38 - 88.11"
